Company Filing History:
Years Active: 2009-2014
Title: The Innovative Contributions of Ellen Paxinos
Introduction
Ellen Paxinos is a notable inventor based in San Jose, CA, who has made significant contributions to the field of biomedical research. With a total of 3 patents to her name, she has focused her work on advancing the understanding and treatment of HIV.
Latest Patents
One of her latest patents is titled "Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs." This invention relates to methods and compositions for determining the altered susceptibility of the human immunodeficiency virus (HIV) to various anti-HIV drugs. Specifically, it involves detecting the presence of mutations in the gene encoding HIV reverse transcriptase that are associated with altered susceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as efavirenz (EFV), nevirapine (NVP), and delavirdine (DLV), as well as the nucleoside reverse transcriptase inhibitor AZT and integrase strand transfer inhibitors.
Career Highlights
Ellen Paxinos is currently employed at Monogram Biosciences, Inc., where she continues to innovate and contribute to the field of HIV research. Her work has been instrumental in developing methods that enhance the understanding of HIV drug resistance.
Collaborations
Throughout her career, Ellen has collaborated with esteemed colleagues, including Neil T Parkin and Soumi Gupta, to further her research and impact in the field.
Conclusion
Ellen Paxinos exemplifies the spirit of innovation in biomedical research, particularly in the fight against HIV. Her contributions through her patents and collaborations highlight her commitment to improving health outcomes for individuals affected by this virus.